Article Sidebar
Views PDF: 156
REVIEW THE PRIMARY RESULT OF VOLUMETRIC MODULATED ARC THERAPY (VMAT) RADIATION THERARY FOR PATIENTS WITH LIMITED STAGE SMALL CELL LUNG CANCER AT K HOSPITAL
Main Article Content
Abstract
Purpose: Our study aims to review somes the clinical, subclinical and early side effects and results to treated in concurrent chemotherapy of limited stage small cell lung cancer at K hospital. Methods: 30 patients with limited stage small cell lung cancer. Who are treated by concurrent chemoradiation therapy, using EP 2cycles and 60Gy of RT and EP 2 cycles after concurrent chemotherapy; using VMAT technique. To review somes the clinical, subclinical and early side effects and results to treated in concurrent chemotherapy of limited stage small cell lung cancer at K hospital. Results: Most of patients were man with the smoke, common symptoms be cough and chest pain, medium tumor size were 5.2 ± 0.8. All cases have mediastinum lymph node in computed tomography scanner. PR of tumor: 96.7%, CR of tumor up to: 60%. Rate of pneumonia early complication grade 2: 3.3%. Esophagitis early complication grade 2: 3.3%. Conclusion: In our study, we found that use VMAT to make to increase the result of risponsed and the side effects of group were low.
Article Details
References
2. ICRU Report No: 62 (1999). International Commision on Radiation Units and Measurements, ICRU Report 62 (1999) Prescribing, recording and reporting photon beam therapy (Supplement to ICRU report 50).
3. Bùi Diệu and cộng sự ( 2010). Tình hình mắc ung thư tại Việt Nam qua số liệu của 6 vùng ghi nhận giai đoạn 2004-2008 Tạp chí ung thư học Việt Nam,. 2010;1/2010:75-77.
4. Nguyễn Bá Đức, Trần Văn Thuấn, Bùi Công Toàn. Ung thư phổi (2007). In: Chẩn đoán và điều trị bệnh ung thư. Hà Nội: NXB Y học; 2007:176-187.
5. Đặng Thanh Hồng, Cs (2005). Hóa trị ung thư phổi tế bào nhỏ đối với người lớn tại Bệnh viện Ung bướu Thành phố Hồ Chí Minh. Y học thành phố Hồ Chí Minh. 2005; Phụ bản tập 9-Số 4:377-383.
6. Võ Văn Xuân (2009). Nghiên cứu áp dụng phác đồ kết hợp hóa - xạ trị trong ung thư phổi đánh giá kết quả điều trị, Đại học Y Hà Nội.
7. Isgrò MA, Bottoni P, Scatena R (2015). Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects. Advances in experimental medicine and biology. 2015;867:125-143.
8. Takada M, Fukuoka M, Kawahara M, et al (2002). Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2002;20(14):3054-3060.
9. Hoàng Trọng Tùng (2022). Đánh giá kết quả hóa xạ trị đồng thời UTPTBN giai đoạn khu trú bằng Cisplatine-Etoposide tại Bệnh viện K.